community HMI 115 hasn't done phase one yet for AGA?
User asks if HMI 115 hasn't done phase 1 for AGA in humans. Conversation includes treatments Min, Fin, and RU.
Search
for
Sort by
Community Join
60-90 / 1000+ resultscommunity Pp405 phase 2a clinical results
PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.
community Slowly Getting There! Progress Update
community 0.5mg Dut, 5mg oral min 1 year 2 months.
community Amplifica and AMP-303 clinical phase 1
Amplifica is testing a compound called AMP-303 for hair loss, but it's not Scube3 or osteopontin. The timing for the results from the clinical trial is unknown.
community Stole from another group for you all to enjoy
community 3 Month Mark Update, Fin 1mg/Min 2ml ED
community can anybody please answer this
community 34M three months of progress so far
community PP405 2a study was a safety study. Some rational explaining.
The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.
community 28M 5MG MIN 0.5MG DUT SINCE JAN 1ST - SIDE, TOP & FRONT UPDATE
community SUBE3 for sale in the gray market?
SCUBE3 is available online but poses risks like tumor promotion and high costs. Users advise against using it due to health concerns and inefficacy as a standalone treatment.
community 3-year fin/min plateau broken? Crown progress update (May 2025 – Present)
community Male 30 US - April 2025 to August 2026 - Oral Min & Fin 2.5/1mg
community Is the ru58841 from rudirect legit?
community Cassiopea Announces Very Positive Interim Analysis Phase 2 Results for Breezula® (Clascoterone) in Treating Androgenetic Alopecia
Breezula® (Clascoterone) showed promising results in a Phase 2 trial for treating hair loss, being as effective as Propecia with no serious side effects. It might be released between 2021-2022, and a related acne treatment with the same active ingredient could be used in the meantime.
community Ru58841 only treatment thoughts
community Selling KY19382 powder a novel activator of Wnt/β-catenin signaling Product
Selling KY19382 powder, a novel activator of Wnt/β-catenin signaling, and Kolliphor EL liquid for vehicle formulation. KY19382 is a growth agonist.
community Phase 3 for PP405 will now start in 2027
community 2 year transformation, 21 yr Male.
community 2022->2026, 3.5 years Fin, no min, trans male
community RU58841 works great!
community Alpicort E: Diffuse thinning/MPB medication, Can't find much info on it?
A user was prescribed Alpicort E, which contains Estradiol Benzoate, Prednisone, and Salicylic Acid, for hair loss and is seeking others' experiences due to concerns about potential side effects.
community Oral fin 1mg, oral min 2.5 mg - 18 months
community 2 months fin + min + dermastamping results
community Follicum releases some data from previous phase 2a trial
Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.
community 2 Years of Dut. Can these miniaturized hairs still recover?
community Progress pics! 2 months fin and min
community 4 Month Progress [Fin + Min] 38M
community Spiro for AGA in Europe
Treatment options for female alopecia androgenetica, discussing the availability of spironolactone online in The Netherlands and other potential treatments like finasteride, minoxidil and RU58841.